abstract the effectiveness of hibiscus sabdariffa l. (hs) in the treatment of risk factors associated with cardiovascular disease is assessed in this review by taking a comprehensive approach to interpreting the randomized clinical trial (rct) results in the context of the available ethnomedical, phytochemical, pharmacological, and safety and toxicity information.